BioCentury
ARTICLE | Financial News

TetraLogic amends IPO

November 11, 2013 8:00 AM UTC

TetraLogic Pharmaceuticals Corp., Malvern, Pa. Business: Cancer Date announced: 11/6/13 Type: IPO To be raised: Up to $96.4 million Shares: 6.4 million Price: $13-$15 Underwriters: Oppenheimer; Guggen...